骨代谢生化指标在绝经后骨质疏松症患者中的应用价值

被引：23

作者：

王冰 ^{[1
,2
]}

曲凡 ^{[1
]}

周坚红 ^{[1
]}

机构：

[1] 浙江大学医学院附属妇产科医院

[2] 浙江省嘉兴市第二医院

来源：

现代妇产科进展 | 2014年 / 23卷 / 02期

关键词：

骨代谢; 生化指标; 绝经后; 骨质疏松症;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

骨代谢生化指标在指导临床监测治疗绝经后骨质疏松症有重要价值,其能反映骨骼系统的整体代谢水平,从而预测骨转换率的高低,为早期防治骨折发生提供理论依据。目前,骨代谢生化指标主要可分为骨形成指标和骨吸收指标两类,前者代表成骨细胞活动及骨形成时的代谢产物,后者代表破骨细胞活动及骨吸收时的代谢产物。本文现就骨代谢生化指标在绝经后骨质疏松症患者中的应用价值做一简要综述。

引用

页码：136 / 138

页数：3

共 17 条

[1]

Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study [J].

Tamaki, J. ;

Iki, M. ;

Kadowaki, E. ;

Sato, Y. ;

Chiba, Y. ;

Akiba, T. ;

Matsumoto, T. ;

Nishino, H. ;

Kagamimori, S. ;

Kagawa, Y. ;

Yoneshima, H. .

OSTEOPOROSIS INTERNATIONAL, 2013, 24 (03) :887-897

[2]

Distribution of serum βCTX in a population-based study of postmenopausal women taking into account different anti-osteoporotic therapies (the FRODOS Cohort) [J].

Kanterewicz, Eduardo ;

Peris, Pilar ;

Puigoriol, Emma ;

Yanez, Aina ;

Rosique, Pau ;

del Rio, Luis .

JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (02) :231-239

[3]

Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation [J].

Cauley, Jane A. ;

Danielson, Michelle E. ;

Greendale, Gail A. ;

Finkelstein, Joel S. ;

Chang, Yue-Fang ;

Lo, Joan C. ;

Crandall, Carolyn J. ;

Neer, Robert M. ;

Ruppert, Kristine ;

Meyn, Leslie ;

Prairie, Beth A. ;

Sowers, MaryFran R. .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (11) :1200-1207

[4]

The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis [J].

Szulc, Pawel .

CLINICAL BIOCHEMISTRY, 2012, 45 (12) :907-919

[5]

Role of serum FSH measurement on bone resorption in postmenopausal women [J].

Garcia-Martin, Antonia ;

Reyes-Garcia, Rebeca ;

Miguel Garcia-Castro, Jose ;

Rozas-Moreno, Pedro ;

Escobar-Jimenez, Fernando ;

Munoz-Torres, Manuel .

ENDOCRINE, 2012, 41 (02) :302-308

[6]

PINP as an aid for monitoring patients treated with teriparatide.[J].Mika Tsujimoto;Peiqi Chen;Akimitsu Miyauchi;Hideaki Sowa;John H. Krege.Bone.2010, 4

[7]

Bone turnover markers: understanding their value in clinical trials and clinical practice [J].